402 results match your criteria: "Centre for Applied Microbiology and Research[Affiliation]"
Comp Funct Genomics
June 2010
Centre for Applied Microbiology and Research, Salisbury, Wiltshire SP4 0JG, UK.
A unique approach, combining defined and reproducible in vitro models with DNA microarrays, has been developed to study environmental modulation of mycobacterial gene expression. The gene expression profiles of samples of Mycobacterium tuberculosis, from independent chemostat cultures grown under defined and reproducible conditions, were found to be highly correlated. This approach is now being used to study the effect of relevant stimuli, such as limited oxygen availability, on mycobacterial gene expression.
View Article and Find Full Text PDFIDrugs
August 1998
Head of Formulation, Centre for Applied Microbiology and Research, Experimental Vaccines Section, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
Cortecs is developing Pseudostat, an oral vaccine derived from Pseudomonas aeruginosa, for the potential treatment and prophylaxis of lung infection with P aeruginosa and Haemophilus influenza, common in respiratory disorders such as cystic fibrosis, bronchitis and bronchiectasis. It is expected that a phase III trial will commence this year, and that a European registration submission will be made by the end of the year [262793]. In January 1998, Cortecs confirmed that phase III trials for Pseudostat for bronchitis are being prepared [276928].
View Article and Find Full Text PDFIDrugs
November 1999
Research Division, Centre for Applied Microbiology and Research, Porton Down, Salisbury, SP4 0JG, UK.
The main theme of this conference was understanding the complex biology of viruses in order to design appropriate vaccines for human use. The use of both plant and animal viruses as vectors for delivery vehicles was widely discussed. These engineered viruses could be delivered in oral formulations or, in the case of plant viruses, grown in the plant host and used as edible vaccines.
View Article and Find Full Text PDFProtein Expr Purif
March 2005
Health Protection Agency, Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire SP4 0JG, UK.
Clostridium botulinum neurotoxins are potently toxic proteins of 150 kDa with specific endopeptidase activity for SNARE proteins involved in vesicle docking and release. Following treatment with trypsin, a fragment of botulinum neurotoxin serotype A that lacks the C-terminal domain responsible for neuronal cell binding, but retains full catalytic activity, can be obtained. Known as the LH(N) fragment, we report the development of a recombinant expression and purification scheme for the isolation of comparable fragments of neurotoxin serotypes B and C.
View Article and Find Full Text PDFClin Exp Immunol
December 2004
Health Protection Agency, Porton Down, Centre for Applied Microbiology and Research, Salisbury, Wiltshire, UK.
Intranasal vaccination may offer practical benefits and better protection against respiratory infections, including tuberculosis. In this paper, we investigated the persistence of the Mycobacterium bovis-strain bacille Calmette-Guerin (BCG) Pasteur, lung granuloma formation and protection against pathogenic tuberculous challenge in mice. A pronounced BCG dose-dependent granulomatous infiltration of the lungs was observed following intranasal, but not after subcutaneous, vaccination.
View Article and Find Full Text PDFJ Gen Virol
October 2004
Public Health Affairs, Centre for Applied Microbiology and Research, Health Protection Agency, Porton Down, Salisbury SP4 0JG, UK.
The complete nucleotide sequences of the small (S) and medium (M) segments of three independent strains of Crimean-Congo haemorrhagic fever (CCHF) virus isolated in Uzbekistan, Iraq and Pakistan have been determined. Partial S and M segment sequences from two additional strains and partial large segment sequences from five strains of CCHF virus have also been obtained. These data have been compiled and compared with published full-length and partial sequences of other CCHF virus strains.
View Article and Find Full Text PDFJ Immunol Methods
May 2004
Centre for Applied Microbiology and Research, Health Protection Agency Porton Down, Porton Down, Salisbury, Wiltshire SP4 0JG, UK.
Detection of Clostridium botulinum neurotoxin (BoNT) neutralising antibodies is currently achieved using the mouse lethality assay (MLA). This technique has provided the majority of the data for vaccine development and, with the increasing use of BoNT as a therapeutic agent, the MLA is the assay of choice to evaluate 'non-responder' antisera. However, the MLA is semi-quantitative and has an animal consumption rate that raises ethical concerns.
View Article and Find Full Text PDFImmunology
March 2004
Health Protection Agency, Porton Down, Centre for Applied Microbiology and Research (CAMR), Salisbury, UK.
We report on a new approach toward protection against tuberculosis, based on passive inoculation with immunoglobulin A (IgA) antibodies. In a mouse model of tuberculous lung infection, intranasal inoculations of mice with an IgA monoclonal antibody (mAb) against the alpha-crystallin antigen of Mycobacterium tuberculosis reduced up to 10-fold the lung bacterial counts at nine days after either aerosol- or intranasal challenge. This effect involved synergism between mAb inoculations shortly before and 3 days after infection.
View Article and Find Full Text PDFMethods Mol Med
November 2003
Health Protection Agency, Centre for Applied Microbiology and Research, Salisbury, Wiltshire, United Kingdom.
Methods Mol Med
November 2003
Health Protection Agency, Centre for Applied Microbiology and Research, Salisbury, Wiltshire, United Kingdom.
Protein Expr Purif
August 2003
Centre for Applied Microbiology and Research, Porton Down, Salisbury, SP4 0JG Wiltshire, UK.
Using polymerase chain reaction, the coding sequence for Erythrina cristagalli lectin (ECL) has been cloned and expressed in Escherichia coli. The amplified DNA sequence of ECL is highly homologous to that previously reported for Erythrina corallodendron lectin (ECorL), confirming the absence of introns in the ECL gene. The polypeptide sequences of ECL and ECorL have been compared and five amino acids have been identified that differentiate the two proteins.
View Article and Find Full Text PDFJ Gen Virol
July 2003
Centre for Applied Microbiology and Research (CAMR), Porton Down, Salisbury SP4 0JG, UK.
Envelopes of retroviruses, including human immunodeficiency virus and simian immunodeficiency virus (SIV), contain host cell proteins that potentially represent novel targets for vaccine development. We show here that sera from rhesus macaques recognized simian major histocompatibility complex (MHC) molecules in response to infection with SIV. Antibodies from these animals did not cross-react with human MHC antigens on mitogen-activated peripheral blood mononuclear cells.
View Article and Find Full Text PDFLancet
April 2003
National Collection of Pathogenic Viruses, Centre for Applied Microbiology and Research, Salisbury, UK.
After eradication of circulating polioviruses, reintroduction might arise from cultured laboratory stocks, or from collections of patients' or environmental samples. In an example of a further class of risk, we recorded poliovirus type 1 in at least four working stocks of what had been identified as various serotypes of human rhinovirus. This finding emphasises the need to urgently assess the possibility of presence of poliovirus, even in apparently well-characterised stocks of other viruses, to screen for the virus where necessary, and to destroy materials in which risk outweighs potential benefit.
View Article and Find Full Text PDFDev Biol (Basel)
July 2003
Centre for Applied Microbiology and Research, Salisbury, UK.
The characterisation and evaluation of the UK licensed human anthrax vaccine depends on several in vivo tests that determine its safety and potency. Assays for the determination of functionally active and/or immunoreactive toxin components and S-layer proteins have been developed and applied to the characterisation of anthrax vaccine. These technologies may support production of consistent and effective vaccines, and may ultimately reduce the requirements for in vivo testing.
View Article and Find Full Text PDFMicrobiology (Reading)
February 2003
Research Division, Centre for Applied Microbiology and Research, Salisbury SP4 0JG, and Division of Oral Biology, Leeds Dental Institute, Clarendon Way, Leeds LS2 9LU, UK.
Dental diseases are among the most prevalent and costly diseases affecting industrialized societies, and yet are highly preventable. The microflora of dental plaque biofilms from diseased sites is distinct from that found in health, although the putative pathogens can often be detected in low numbers at normal sites. In dental caries, there is a shift towards community dominance by acidogenic and acid-tolerant Gram-positive bacteria (e.
View Article and Find Full Text PDFMicrobiology (Reading)
November 2002
Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire SP4 0JG, UK1.
Inferred amino acid sequences of the methyl coenzyme-M reductase (mcrA) gene from five different methanogen species were aligned and two regions with a high degree of homology flanking a more variable region were identified. Analysis of the DNA sequences from the conserved regions yielded two degenerate sequences from which a forward primer, a 32-mer, and a reverse primer, a 23-mer, could be derived for use in the specific PCR-based detection of methanogens. The primers were successfully evaluated against 23 species of methanogen representing all five recognized orders of this group of Archaea, generating a PCR product between 464 and 491 bp.
View Article and Find Full Text PDFMol Microbiol
October 2002
Research Division, Centre for Applied Microbiology and Research, Wiltshire, UK.
Progress towards understanding the molecular basis of virulence in Clostridium difficile has been hindered by the lack of effective gene transfer systems. We have now, for the first time, developed procedures that may be used to introduce autonomously replicating vectors into this organism through their conjugative, oriT-based mobilization from Escherichia coli donors. Successful transfer was achieved through the use of a plasmid replicon isolated from an indigenous C.
View Article and Find Full Text PDFInfect Immun
September 2002
Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire, United Kingdom.
In order to plan for the wide-scale introduction of meningococcal C conjugate (MCC) vaccine for United Kingdom children up to 18 years old, phase II trials were undertaken to investigate whether there was any interaction between MCC vaccines conjugated to tetanus toxoid (TT) or a derivative of diphtheria toxin (CRM(197)) and diphtheria-tetanus vaccines given for boosting at school entry or leaving. Children (n = 1,766) received a diphtheria-tetanus booster either 1 month before, 1 month after, or concurrently with one of three MCC vaccines conjugated to CRM(197) or TT. All of the MCC vaccines induced high antibody responses to the serogroup C polysaccharide that were indicative of protection.
View Article and Find Full Text PDFProtein Expr Purif
July 2002
Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire SP4 0JG, UK.
Clostridium botulinum neurotoxin type A is a potently toxic protein of 150 kDa with specific endopeptidase activity for the SNARE protein SNAP-25. Proteolytic cleavage of BoNT/A with trypsin leads to removal of the C-terminal domain responsible for neuronal cell binding. Removal of this domain result in a catalytically active, non-cell-binding derivative termed LH(N)/A.
View Article and Find Full Text PDFJ Biol Chem
September 2002
Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.
Clostridial neurotoxins potently and specifically inhibit neurotransmitter release in defined cell types. Here we report that a catalytically active derivative (termed LH(N)/A) of the type A neurotoxin from Clostridium botulinum has been coupled to a lectin obtained from Erythrina cristagalli to form a novel conjugate. This conjugate exhibits an in vitro selectivity for nociceptive afferents compared with the anatomically adjacent spinal neurons, as assessed using in vitro primary neuronal culture systems to measure inhibition of release of neurotransmitters.
View Article and Find Full Text PDFInfect Immun
July 2002
Centre for Applied Microbiology and Research, Salisbury SP4 0JG, United Kingdom.
Immunological and epidemiological evidence suggests that the development of natural immunity to meningococcal disease results from colonization of the nasopharynx by commensal Neisseria spp., particularly with N. lactamica.
View Article and Find Full Text PDFCurr Top Microbiol Immunol
June 2002
Centre for Applied Microbiology and Research, Porton Down, Salisbury, Wiltshire SP4 0JG, UK.
Virology
February 2002
Centre for Applied Microbiology and Research, Salisbury SP4 0JG, United Kingdom.
Oral-gastric delivery of vaccines is a preferred route of immunization and is particularly relevant to the development of vaccine-vector systems. We have investigated the ability of a replication deficient (E1-deleted) adenovirus construct (RAd68), which efficiently expresses the measles virus nucleocapsid (N) protein under the control of the strong HCMV IE promoter, to elicit antibody and cytotoxic T cell (CTL) responses in mice following intragastric administration. Measles virus N protein-specific CTL memory and serum antibody responses were analyzed in a total of 140 mice at time points 2-51 weeks after immunization either with a single dose of 10(8) pfu RAd68 or with a fivefold higher dose.
View Article and Find Full Text PDFMicrobiology (Reading)
January 2002
Centre for Applied Microbiology and Research (CAMR), Porton Down, Salisbury, Wiltshire SP4 0JG, UK1.
A nitroreductase with distinct properties that can activate the prodrug 5-aziridinyl-2,4-dinitrobenzamide (CB 1954) was isolated from Bacillus amyloliquefaciens. The encoding gene was identified as a homologue of the ywrO of Bacillus subtilis, and was obtained as a PCR product by reverse genetics, cloned and the entire nucleotide sequence determined. The gene was found to reside between homologues of the B.
View Article and Find Full Text PDF